skip to main content

H.R. 3648 (114th): Gluten in Medicine Disclosure Act of 2015


The text of the bill below is as of Sep 29, 2015 (Introduced). The bill was not enacted into law.


I

114th CONGRESS

1st Session

H. R. 3648

IN THE HOUSE OF REPRESENTATIVES

September 29, 2015

(for himself and Mrs. Lowey) introduced the following bill; which was referred to the Committee on Energy and Commerce

A BILL

To amend the Federal Food, Drug, and Cosmetic Act to require the label of drugs intended for human use to contain a parenthetical statement identifying the source of any ingredient constituting or derived from a grain or starch-containing ingredient.

1.

Short title

This Act may be cited as the Gluten in Medicine Disclosure Act of 2015.

2.

Labeling of source of human drug ingredients constituting or derived from a grain or starch-containing ingredient

(a)

Misbranding

Section 502 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 352) is amended by adding at the end the following:

(dd)

If it is a drug—

(1)

that is intended for human use;

(2)

that contains an ingredient (other than a polyol) that constitutes or is derived from a grain or starch-containing ingredient; and

(3)

whose label fails to include a parenthetical statement identifying the source of the ingredient so constituted or derived.

.

(b)

Applicability

Section 502(dd) of the Federal Food, Drug, and Cosmetic Act, as added by subsection (a) of this section, shall apply beginning on the sooner of—

(1)

a date to be determined by the Secretary of Health and Human Services; and

(2)

the date that is 2 years after the date of the enactment of this Act.